Carol Ryan is a Heard on the Street columnist based in London, where she covers European energy companies, property and the ...

Speakers for the events will include leading scientists from The Institute for Protein Innovation (IPI), Pfizer, GSK, ACROBiosystems, Bio-Techne, Curia, ImmunoPrecise Antibodies (IPA), Ordaos, The ...

Large and mid-cap vaccine makers are, as of now, unworried about their 2025 pipelines in the face of research funding ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted on recommendations for several ...

Adding narrowband ultraviolet B (UVB) phototherapy to oral treatment with ritlecitinib (Litfulo) enhanced repigmentation in ...

CDC panel expands Pfizer and GSK RSV vaccine use to high-risk adults 50–59, building on earlier recommendations for older ...

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...

Some justices may be skeptical of a bid by GSK, Pfizer and others to overturn ruling allowing lawsuits to proceed over claims ...

The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...

GSK GSK and Pfizer PFE announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on ...